WASHINGTON—The U.S. government will soon begin hiring experts and collecting the data needed to launch direct negotiations over prescription drug prices for older and disabled people, a top Biden administration official told Reuters. President Joe Biden last week signed into law the Inflation Reduction Act, introducing new policies to tackle climate change, taxes and the…
Search results for: cancer

Rheumatologist Reflects on Her Path from Practice to Teaching to Research
Anne R. Bass, MD, a professor of medicine at Weill Cornell Medical College/Hospital for Special Surgery, New York, has had a unique career path combining clinical practice with academia. Dr. Bass knew “pretty early” in her academic career that she would be going into medicine. She loved science, but also knew that she wanted to…

Dermatologist, Rheumatologist Discuss Refractory Cutaneous Lupus Case
As a dermatologist/internist with a career-long subspecialty interest in the cutaneous manifestations of the rheumatic diseases, I found the case of refractory acute cutaneous lupus by Samantha C. Shapiro, MD, in the June 2022 issue of The Rheumatologist intriguing in several ways, and I felt my perspectives on this case might provide additional educational value…

Healthy Lifestyle Behaviors Lower Women’s Risk of Developing Rheumatoid Arthritis
Using data from cohorts with detailed lifestyle data and lengthy follow-up, Hahn et al. demonstrated that healthy lifestyle behaviors are associated with a lower risk of developing rheumatoid arthritis (RA), concluding that a substantial proportion of RA may be preventable.

A Guiding Light for RA: Insights into Clinical Decision Making, Drug Safety & More
The treatment and management of rheumatoid arthritis (RA) is ever evolving. Here Clifton O. Bingham, MD, discusses the application of RA guidelines, the most recent drug safety information and more.

Just in Case: Understanding Rheumatoid Arthritis Through Patient Cases
Uzma Haque, MD, addressed the management of difficult-to-treat rheumatoid arthritis, using patient case reports to demonstrate clinical decision-making, during a session of the 18th Annual Advances in the Diagnosis & Treatment of the Rheumatic Diseases symposium.

JAK Inhibitors: Are All Promises Fulfilled?
A decade after JAK inhibitors were approved, this EULAR 2022 session looks at whether the drugs have lived up to expectations.

Clinical Guidance & Recommendation Updates for Vasculitis, axSpA & More
In this EULAR 2022 session, new & revised treatment recommendations for ANCA-associated vasculitis, axial spondyloarthritis & rheumatoid arthritis were presented.

Keep ACR’s Advocacy Voice Strong with the American Medical Association
As the result of years of coalition work with partners at the AMA, the ACR recently celebrated a major advocacy win when the FTC announced an investigation of PBM business practices. Join or renew your AMA membership before Sept. 1 so the ACR can keep delegate seats to drive action within the AMA.

ACR-FDA Summit Focuses on Study Design, Safety Considerations
Safety considerations and data sources are crucial to consider when designing studies for rheumatology treatments, according to presenters at the 2022 ACR-FDA Summit.
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 83
- Next Page »